Targeting Inflammation and Fibrosis in Lipedema: The Potential Role of Glucagon-like Peptide-1 Receptor Agonist Therapies.
- DOI
- 10.1097/dss.0000000000005172
- Published
- 2026 Jun 1
- Container
- Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/dss.0000000000005172,
title = {Targeting Inflammation and Fibrosis in Lipedema: The Potential Role of Glucagon-like Peptide-1 Receptor Agonist Therapies.},
author = {Mohseni Y and Vazirnia A and Minokadeh A and Amron DM and Coleman WP 3rd},
year = {2026},
journal = {Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]},
doi = {10.1097/dss.0000000000005172},
url = {https://doi.org/10.1097/dss.0000000000005172}
}RIS
TY - JOUR TI - Targeting Inflammation and Fibrosis in Lipedema: The Potential Role of Glucagon-like Peptide-1 Receptor Agonist Therapies. AU - Mohseni Y AU - Vazirnia A AU - Minokadeh A AU - Amron DM AU - Coleman WP 3rd PY - 2026 JO - Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] DO - 10.1097/dss.0000000000005172 UR - https://doi.org/10.1097/dss.0000000000005172 ER -
APA
Y, M., A, V., A, M., DM, A., & 3rd, C. W. (2026). Targeting Inflammation and Fibrosis in Lipedema: The Potential Role of Glucagon-like Peptide-1 Receptor Agonist Therapies.. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. https://doi.org/10.1097/dss.0000000000005172
Source records
- pubmed · retrieved 2026-09-26T18:54:34.288Z